Doximity Q3 net income at USD 61.6 million, down 18 percent
I'm PortAI, I can summarize articles.
Doximity Inc. reported Q3 fiscal 2026 net income of USD 61.6 million, down 18% year-over-year, with total revenues of USD 185.1 million, a 10% increase. Adjusted EBITDA was USD 111.4 million, with a 60% margin. Operating cash flow decreased by 7% to USD 60.9 million. The company saw record engagement, with over 1 million active prescribers and 300,000 users of new AI products. Doximity announced a stock repurchase program of up to USD 500 million and updated its revenue guidance for the fiscal year to between USD 642.5 million and USD 643.5 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments